KKR Private Equity Net Assets Soar 88% on Strong Investment Growth

TL;DR

**KKR's private equity arm is on a tear, nearly doubling net assets and aggressively deploying capital, signaling strong bullish momentum for investors.**

AI Summary

KKR Private Equity Conglomerate LLC reported a significant increase in net assets and investment income for the nine months ended September 30, 2025. Net assets surged to $8,164,760 thousand from $4,343,385 thousand at December 31, 2024, representing an 88% increase. Investment income for the nine months ended September 30, 2025, rose to $72,930 thousand, a substantial increase from $24,130 thousand in the same period of 2024. However, net investment loss also widened to $109,162 thousand from $38,286 thousand year-over-year, primarily due to higher operating expenses, including a performance participation allocation of $151,484 thousand and management fees of $53,174 thousand. The company experienced a net increase in net assets from operations of $762,080 thousand for the nine months ended September 30, 2025, compared to $278,319 thousand in the prior year. Investments at fair value significantly increased to $6,909,836 thousand from $3,918,519 thousand, reflecting substantial capital deployment into portfolio companies, with Information Technology and Health Care being the largest sectors. Cash and cash equivalents also saw a substantial rise to $1,868,983 thousand from $601,529 thousand.

Why It Matters

This substantial growth in KKR Private Equity Conglomerate LLC's net assets and investment portfolio signals robust capital deployment and potentially strong returns for investors, especially given the significant increase in investments at fair value. The competitive landscape in private equity demands aggressive capital allocation, and KKR's activity suggests it is actively pursuing and securing attractive opportunities, particularly in the Information Technology and Health Care sectors. This could lead to increased dividends or capital appreciation for shareholders, while also indicating a healthy environment for the portfolio companies, potentially benefiting their employees and customers through growth and innovation. The firm's ability to raise significant capital, as evidenced by the $3,216,065 thousand in consideration from share issuance, underscores investor confidence in its strategy.

Risk Assessment

Risk Level: medium — The risk level is medium due to the significant increase in investments at fair value to $6,909,836 thousand, which are predominantly Level III assets, indicating less observable inputs and higher valuation subjectivity. While net assets increased substantially, the net investment loss widened to $109,162 thousand, driven by high operating expenses like the $151,484 thousand performance participation allocation, which could impact future profitability if investment gains do not keep pace.

Analyst Insight

Investors should closely monitor KKR Private Equity Conglomerate LLC's future performance, particularly the realized gains from its substantial Level III investments. Given the aggressive capital deployment and increased net assets, consider this a growth-oriented investment, but be aware of the inherent valuation risks in private equity and the impact of high operating expenses on net investment income.

Financial Highlights

debt To Equity

N/A

revenue

$72,930

operating Margin

N/A

total Assets

$8,797,605

total Debt

N/A

net Income

$762,080

eps

N/A

gross Margin

N/A

cash Position

$1,868,983

revenue Growth

+202%

Revenue Breakdown

Key Numbers

• $8,164,760 — Net Assets (Increased 88% from $4,343,385 thousand at December 31, 2024)
• $6,909,836 — Investments at Fair Value (Increased from $3,918,519 thousand at December 31, 2024, showing significant capital deployment)
• $72,930 — Total Investment Income (For the nine months ended September 30, 2025, up from $24,130 thousand in 2024)
• $109,162 — Net Investment Loss (For the nine months ended September 30, 2025, widened from $38,286 thousand in 2024)
• $151,484 — Performance Participation Allocation (Operating expense for the nine months ended September 30, 2025)
• $762,080 — Net Increase in Net Assets from Operations (For the nine months ended September 30, 2025, up from $278,319 thousand in 2024)
• $3,216,065 — Consideration from Issuance of Shares (For the nine months ended September 30, 2025, indicating strong capital raising)
• 29.3% — Information Technology Sector Allocation (Largest sector in the investment portfolio as of September 30, 2025)
• 24.4% — Health Care Sector Allocation (Second largest sector in the investment portfolio as of September 30, 2025)

Key Players & Entities

• KKR Private Equity Conglomerate LLC (company) — Registrant
• Goldman, Sachs & Co. (company) — Foreign Currency Forward Contracts Counterparty
• Nomura International PLC (company) — Foreign Currency Forward Contracts Counterparty
• Barclays Bank PLC (company) — Foreign Currency Forward Contracts Counterparty
• Cotiviti Holdings, Inc. (company) — Portfolio Company
• Omnissa (company) — Portfolio Company
• SEC (regulator) — U.S. Securities and Exchange Commission
• Manager (company) — Affiliate managing KKR Private Equity Conglomerate LLC

FAQ

Risk Factors

• Valuation of Investments [high — financial]: The fair value of KKR's investments is determined by management and may not be indicative of future realizable values. As of September 30, 2025, investments were valued at $6,909,836 thousand, a substantial increase from $3,918,519 thousand at December 31, 2024, highlighting the sensitivity to valuation methodologies.
• Performance Participation Allocation [high — financial]: The company recorded a performance participation allocation of $151,484 thousand for the nine months ended September 30, 2025, a significant increase from $52,896 thousand in the prior year. This expense directly impacts net income and can fluctuate based on investment performance.
• Sector Concentration Risk [medium — market]: The investment portfolio shows significant concentration in the Information Technology (29.3%) and Health Care (24.4%) sectors as of September 30, 2025. Adverse developments in these specific sectors could disproportionately impact the overall performance of KKR's investments.
• Reliance on Manager and Affiliates [medium — operational]: The company has balances due to and from its Manager and affiliates, totaling $29,566 thousand due to and $375 thousand due from as of September 30, 2025. Dependence on these related parties for management and operational services introduces potential conflicts of interest or operational disruptions.
• Increased Operating Expenses [medium — financial]: Total operating expenses, including management fees ($53,174 thousand) and performance participation allocation ($151,484 thousand), have risen substantially for the nine months ended September 30, 2025. This increase in expenses contributed to a widening net investment loss of $109,162 thousand.
• Foreign Currency Fluctuations [low — financial]: The company holds foreign currencies and engages in foreign currency forward contracts, with unrealized depreciation on forward contracts amounting to $68,992 thousand as of September 30, 2025. Fluctuations in foreign exchange rates can impact the value of investments and reported results.

Industry Context

The private equity sector continues to see robust capital deployment, with KKR Private Equity Conglomerate LLC demonstrating significant growth in its investment portfolio. Key sectors like Information Technology and Health Care remain attractive, reflecting broader industry trends of innovation and demand. The competitive landscape is characterized by large, established players like KKR competing for deals, necessitating strong performance and capital raising capabilities.

Regulatory Implications

As a private equity firm, KKR is subject to various financial regulations, including those related to investment management, disclosures, and capital requirements. The significant increase in assets and the complexity of its investment strategies necessitate ongoing compliance with evolving regulatory frameworks to ensure investor protection and market integrity.

What Investors Should Do

1. Monitor expense ratios, particularly performance participation and management fees, in relation to investment income.
2. Analyze the sector allocation and underlying performance of Information Technology and Health Care investments.
3. Evaluate the company's capital raising success and deployment strategy.
4. Assess the impact of foreign currency fluctuations on reported results.

Key Dates

• 2025-09-30: Nine Months Ended — Reporting period showing substantial growth in net assets and investment income, alongside increased operating expenses and capital deployment.
• 2024-12-31: Year-End — Prior period benchmark for net assets ($4,343,385 thousand) and investments at fair value ($3,918,519 thousand).
• 2024-09-30: Nine Months Ended — Prior year period for comparison, showing significantly lower investment income ($24,130 thousand) and net increase in net assets from operations ($278,319 thousand).

Glossary

Net Assets

The total value of an investment company's assets minus its liabilities. It represents the net worth of the company available to shareholders. (Key indicator of the company's overall size and growth, which increased by 88% to $8,164,760 thousand.)

Investments at Fair Value

The current market value of the company's investment holdings, determined by management. (Represents the largest asset category, showing significant capital deployment with a value of $6,909,836 thousand as of September 30, 2025.)

Investment Income

Revenue generated from the company's investments, such as dividends, interest, and capital gains. (Total investment income rose to $72,930 thousand for the nine months ended September 30, 2025, indicating improved portfolio earnings.)

Net Investment Loss

The difference between investment income and operating expenses, where expenses exceed income. (Widened to $109,162 thousand for the nine months ended September 30, 2025, primarily due to increased operating expenses.)

Performance Participation Allocation

A fee charged by the investment manager based on the investment's performance, typically a percentage of profits above a certain hurdle rate. (A significant operating expense of $151,484 thousand for the nine months ended September 30, 2025, directly impacting profitability.)

Management Fee Expense

Fees paid to the investment manager for managing the company's assets, usually a percentage of assets under management. (Amounted to $53,174 thousand for the nine months ended September 30, 2025, contributing to overall operating expenses.)

Net Increase in Net Assets from Operations

The net change in the company's net assets resulting from its operational activities (investment income less expenses). (Showed a substantial increase to $762,080 thousand for the nine months ended September 30, 2025, reflecting strong operational performance.)

Cash and Cash Equivalents

Highly liquid short-term investments that can be readily converted to cash. (Increased significantly to $1,868,983 thousand, providing ample liquidity for operations and future investments.)

Year-Over-Year Comparison

KKR Private Equity Conglomerate LLC has experienced a transformative period, with net assets nearly doubling from $4,343,385 thousand to $8,164,760 thousand year-over-year. Investment income has surged by over 200% to $72,930 thousand, driven by increased dividend income. However, this growth has been accompanied by a significant rise in operating expenses, including a substantial performance participation allocation, leading to a wider net investment loss. Despite this, the net increase in net assets from operations has more than doubled, reflecting strong overall operational gains and successful capital deployment into its investment portfolio.

Filing Documents

• kkr-20250930.htm (10-Q) — 2264KB
• k-pecq3202510xqexhibit101.htm (EX-10.1) — 23KB
• k-pecq3202510xqexhibit102.htm (EX-10.2) — 24KB
• k-pecq3202510xqex311.htm (EX-31.1) — 9KB
• k-pecq3202510xqex312.htm (EX-31.2) — 9KB
• k-pecq3202510xqex313.htm (EX-31.3) — 9KB
• k-pecq3202510xqex321.htm (EX-32.1) — 4KB
• k-pecq3202510xqex322.htm (EX-32.2) — 4KB
• k-pecq3202510xqex323.htm (EX-32.3) — 4KB
• kkr-20250930_g1.jpg (GRAPHIC) — 21KB
• kkr-20250930_g2.jpg (GRAPHIC) — 20KB
• kkr-20250930_g3.jpg (GRAPHIC) — 15KB
• 0001957845-25-000085.txt ( ) — 10406KB
• kkr-20250930.xsd (EX-101.SCH) — 52KB
• kkr-20250930_cal.xml (EX-101.CAL) — 71KB
• kkr-20250930_def.xml (EX-101.DEF) — 307KB
• kkr-20250930_lab.xml (EX-101.LAB) — 552KB
• kkr-20250930_pre.xml (EX-101.PRE) — 435KB
• kkr-20250930_htm.xml (XML) — 1700KB

- Financial Information

Part I - Financial Information 1

Financial Statements

Item 1. Financial Statements 1 Consolidated Statements of Assets and Liabilities as of September 30, 2025 (Unaudited) and December 31, 2024 1 Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2025 and 2024 (Unaudited) 2 Consolidated Statements of Changes in Net Assets for the Three and Nine Months Ended September 30, 2025 and 2024 (Unaudited) 3 Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024 (Unaudited) 5 Condensed Consolidated Schedules of Investments as of September 30, 2025 (Unaudited) and December 31, 2024 7

Notes to Consolidated Financial Statements (Unaudited) 13

Notes to Consolidated Financial Statements (Unaudited) 13

M anagement's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. M anagement's Discussion and Analysis of Financial Condition and Results of Operations 34

Quantitative and Qualitative Disclosures about Market Risk

Item 3. Quantitative and Qualitative Disclosures about Market Risk 51

Controls and Procedures 53

Item 4. Controls and Procedures 53

- Other Information

Part II - Other Information 54

Legal Proceedings 54

Item 1. Legal Proceedings 54

Risk Factors 54

Item 1A. Risk Factors 54

Unregistered Sales of Equity Securities and Use of Proceeds 55

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 55

Defaults Upon Senior Securities 56

Item 3. Defaults Upon Senior Securities 56

Mine Safety Disclosures 56

Item 4. Mine Safety Disclosures 56

Other Information 56

Item 5. Other Information 56

Exhibits 57

Item 6. Exhibits 57 Signatures 58 Special Note Regarding Forward-Looking Statements Some of the statements in this Quarterly Report on Form 10-Q constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), because they relate to future events or our future performance or financial condition. The forward-looking statements contained in this Quarterly Report on Form 10-Q may include statements as to: our future operating results; our business prospects and the prospects of the portfolio companies we own and control; the impact of the acquisitions that we expect to make; our ability to raise sufficient capital to execute our acquisition strategies; the ability of the Manager (as defined herein) to source adequate acquisition opportunities to efficiently deploy capital; the ability of our portfolio companies to achieve their objectives; our current and expected financing arrangements; changes in the general interest rate environment; the adequacy of our cash resources, financing sources and working capital; the timing and amount of cash flows, distributions and dividends, if any, from our portfolio companies; our contractual arrangements and relationships with third parties; actual and potential conflicts of interest with the Manager or any of its affiliates; the dependence of our future success on the general economy and its effect on the industries in which we own and control portfolio companies; our use of financial leverage; the ability of the Manager to identify, acquire and support our portfolio companies; the ability of the Manager or its affiliates to attract and retain highly talented professionals; our ability to structure acquisitions and joint ventures in a tax-efficient manner and the effect of changes to tax legislation and our tax position; and the tax status of the e

Financial Information

Part I. Financial Information

Financial Statements

Item 1. Financial Statements KKR PRIVATE EQUITY CONGLOMERATE LLC CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES (UNAUDITED) (Amounts in Thousands, Except Share and Per Share Data) September 30, 2025 December 31, 2024 Assets Investments at fair value (cost of $ 5,589,172 and $ 3,585,860 , respectively) $ 6,909,836 $ 3,918,519 Cash and cash equivalents 1,868,983 601,529 Foreign currencies at fair value (cost of $ 193 and $ 1 , respectively) 194 1 Prepaids and other assets 722 240 Dividends receivable 6,324 2,366 Unrealized appreciation on foreign currency forward contracts 4,354 30,319 Due from Manager 375 — Deferred financing costs, net 6,817 5,009 Total assets 8,797,605 4,557,983 Liabilities Accrued performance participation allocation 151,285 — Accrued shareholder servicing fees and distribution fees 296,058 176,891 Directors' fees and expenses payable 151 151 Other accrued expenses and liabilities 8,921 5,153 Deferred income taxes 77,872 21,200 Unrealized depreciation on foreign currency forward contracts 68,992 — Due to Manager and affiliates 29,566 11,203 Total liabilities 632,845 214,598 Commitments and contingencies (Note 9) Net assets $ 8,164,760 $ 4,343,385 Net assets are comprised of Class D Shares, 5,326,082 and 0 shares authorized, issued and outstanding, respectively $ 169,363 $ — Class I Shares, 35,084,933 and 31,054 shares authorized, issued and outstanding, respectively 1,144,993 899 Class S Shares, 154,204 and 0 shares authorized, issued, and outstanding, respectively 4,652 — Class U Shares, 45,878,569 and 137,406 shares authorized, issued and outstanding, respectively 1,384,343 3,701 Class R-D Shares, 11,273,752 and 10,419,393 shares authorized, issued and outstanding, respectively 356,619 294,461 Class R-I Shares, 60,195,197 and 51,968,235 shares authorized, issued and outstanding, respectively 1,947,111 1,501,848 Class R-U Shares, 103,329,225 and 93,038,669 shares authorized, issued and outstandin

View Full Filing

View this 10-Q filing on SEC EDGAR